EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Late-Onset Neutropenia in Clozapine Users: Unrelated or Drug-Induced? A Case-Registry Analysis of Incidence, Characteristics, and Rechallenge Attempts

Aviv Segev, Risha Govind, Ebenezer Oloyede iD, Cecilia Casetta, Megan Pritchard, Amelia Jewell, Matthew Broadbent, Harsimran Kaur Makan iD, David Taylor, James MacCabe

Schizophrenia Bulletin · 2025

DOI: 10.1093/schbul/sbaf148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2025. Verfasst von Aviv Segev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents, Schizophrenia, Registries. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Clozapine treatment carries a risk of blood dyscrasias (BD) and requires indefinite monitoring in many jurisdictions, a major factor in its under-utilization. Although previous studies suggest BD risk is highest early in treatment, BD events have also been reported after many years. This study compares early vs late (>6 months) suspected blood dyscrasias (SBD) and examines rechallenge outcomes as a marker for clozapine-related causation. Study Design A retrospective analysis of electronic health records from a large UK mental health service gathered demographic data, characteristics of SBD events, and outcomes of clozapine rechallenge, defined as reinitiation after SBD-related discontinuation. These variables were compared between early- and late-onset SBD groups using a 6-month treatment duration cutoff. Study Results Of 130 patients with SBD leading to clozapine cessation, 59 had early-onset SBD. The incidence rate before 6 months was 5.54% per year vs 0.53% after 6 months, reflecting an incidence rate ratio of 10.4. Early-onset patients were younger, received lower clozapine doses, and had fewer concurrent antipsychotics. Of 81 rechallenge attempts, 71 (87.7%) were successful, with a mean follow-up of 2.5 years. No significant differences in characteristics or rechallenge outcomes were found between the early- and late-onset groups. Conclusions Though less frequent, late-onset SBD shares similar characteristics with early-onset SBD and has a comparable risk of recurrence on clozapine rechallenge. Vast majority of clozapine rechallenges are successful, including early-onset BD, suggesting they are not clozapine-induced. However, clozapine-induced BD, defined by recurrence upon rechallenge, may rarely occur even after years of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAntipsychotic AgentsSchizophreniaRegistriesNeutropeniaHumansFemaleRetrospective StudiesMaleAdultUnited KingdomIncidenceMiddle Aged

Stichwörter der Autor:innen

adherenceblood dyscrasiaschizophreniatreatment resistance

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, United Kingdom.
  • NIHR Biomedical Research Centre for Mental Health South London and Maudsley NHS, London, SE5 8AF, United Kingdom.
  • School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.
  • Shalvata Mental Health Centre, Hod Hasharon, 4534708, Israel.
  • Pharmacy Department, South London and Maudsley NHS Foundation Trust, London, SE5 8AZ, United Kingdom.
  • Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, United Kingdom.

ORCID-Profile: Ebenezer Oloyede, Harsimran Kaur Makan

Zitieren

APA

Segev, A., Govind, R., Oloyede, E., Casetta, C., Pritchard, M., Jewell, A., Broadbent, M., Makan, H. K., Taylor, D., & MacCabe, J. (2025). Late-Onset Neutropenia in Clozapine Users: Unrelated or Drug-Induced? A Case-Registry Analysis of Incidence, Characteristics, and Rechallenge Attempts. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbaf148

Vancouver

Segev A, Govind R, Oloyede E, Casetta C, Pritchard M, Jewell A, et al. Late-Onset Neutropenia in Clozapine Users: Unrelated or Drug-Induced? A Case-Registry Analysis of Incidence, Characteristics, and Rechallenge Attempts. Schizophrenia Bulletin. 2025. doi:10.1093/schbul/sbaf148

BibTeX
@article{Segev2025,
  author = {Segev, Aviv and Govind, Risha and Oloyede, Ebenezer and Casetta, Cecilia and Pritchard, Megan and Jewell, Amelia and Broadbent, Matthew and Makan, Harsimran Kaur and Taylor, David and MacCabe, James},
  title = {Late-Onset Neutropenia in Clozapine Users: Unrelated or Drug-Induced? A Case-Registry Analysis of Incidence, Characteristics, and Rechallenge Attempts},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  doi = {10.1093/schbul/sbaf148}
}
Kostenlos starten →